Healthcare leaders hold sharply different views on how close artificial intelligence is to practicing medicine independently. But three executives from across the industry agree on a central point: the future of AI in medicine hinges less on model performance than on accountability, governance, and clinician trust.
Federal support for AI research, regulatory modernization, and pilot programs has fueled expectations that conversational AI will take on a larger role in patient care over the coming decade. The Trump Administration has moved to accelerate AI adoption in healthcare by easing regulatory barriers and encouraging broader use in clinical care, research, and administrative operations. Already, AI is handling patient communications and, in some cases, prescription refills.
Clinical reasoning has advanced faster than many realize
Dr. Bob Taylor, chief product strategist at Altera Digital Health, said the underlying technology has progressed more quickly than many observers assume. "From a technical standpoint, some of what people assume is still years away is actually already here," Taylor said. "We can now perform sophisticated clinical reasoning over complete free-text records - this was something that previously required 100% structured, coded data mapped to SNOMED or ICD-10 codes. That shift is significant."
Taylor argued that healthcare organizations should focus on building governance structures that allow AI to apply vetted clinical knowledge consistently across patient populations. The process begins with physicians and nurses establishing evidence-based standards of care before AI ever analyzes an individual patient. "Before any AI recommendation is surfaced, there must be a definitive, traceable standard of truth that the organization has agreed upon," he said. Under this approach, AI functions as a decision-support engine that continuously compares patient information against clinician-approved guidelines.
Dr. Niki Panich, chief medical officer at Penguin AI, pointed out that limited autonomous AI already operates in clinical settings. "If you mean narrow, bounded autonomy, a machine that renders a clinical decision with no physician in the loop, we crossed that line in 2018," Panich said, citing FDA-authorized autonomous diabetic retinopathy screening systems. "So 'autonomous AI provider' isn't a forecast. It exists. In one disease. On one image. At the screening tier." He cautioned that this success should not be mistaken for evidence that AI is approaching the capabilities of a general physician. "If you mean a general clinician that takes an undifferentiated patient, works up, diagnoses, prescribes, and owns the outcome, we are nowhere close," he said. "I'd say a decade-plus for anything resembling broad autonomy."
Accountability remains the industry's defining challenge
Despite differing assessments of AI's maturity, all three experts converged on the same issue: someone must remain responsible for clinical decisions. Dr. Jay Anders, chief medical officer at Medicomp Systems, put it bluntly. "The biggest issue here is the one of accountability. Accuracy and trust run a close second," Anders said. "We love to personify AI as a human replacement; however, humans are the ones who must remain responsible."
Anders drew a comparison to automobile licensing. "Consider that we require a driver's license for anyone behind the wheel of a car, yet we seem to be rushing to let AI take over the provision of healthcare with little or no oversight," he said. "Why wouldn't we hold AI to the same level of accountability when it comes to providing healthcare in any form?" Taylor reached a similar conclusion, arguing that AI should always operate within predefined clinical boundaries established by physicians rather than generating care recommendations on its own.
Panich called for governance that is as formalized as credentialing, with clearly defined responsibilities, transparency, and oversight. "The safeguards have to be real and enforceable," he said. "First, a human stays in the loop with clear, named accountability, so there is always a clinician responsible for the care and never a black box acting alone." He also pushed for "glass-box transparency," detailed audit trails, validation in the populations where AI will actually be deployed, and governance that can suspend or revoke autonomous tools following safety events.
Regulation, reimbursement, and the path forward
The three executives identified different federal initiatives as most likely to accelerate responsible AI adoption. Taylor pointed to the need for objective benchmarking. "Right now, the landscape is essentially the Wild West," he said. He argued that healthcare needs the equivalent of the Office of the National Coordinator for Health Information Technology's meaningful use certification program - trusted benchmarks that health systems can rely upon when selecting AI for Healthcare tools. "Healthcare organizations, most of which don't have the resources to conduct this kind of rigorous experimentation on their own, would benefit enormously from shared best practices."
Panich pointed to the FDA's final Predetermined Change Control Plan guidance as the most consequential development. AI models degrade as patient populations and clinical environments change, and allowing developers to update and validate models without repeatedly restarting the regulatory process could keep deployed systems accurate while encouraging broader adoption. "Three-to-five-year impact is exactly its window because the effect is cumulative, not a single launch," Panich said. But he cautioned that regulatory modernization alone is not enough. "A pathway only matters if there's money on the other side. Pair it with payment reform and it's decisive. Leave payment broken and it's merely necessary."
Anders took a more pragmatic view, arguing that AI's greatest near-term value lies in improving everyday communication between clinicians and patients. "With the introduction of AI, medical issues can be flagged much more quickly, enabling providers to get back with their patients in a more timely manner," he said. Because clinicians remain directly involved, Anders sees relatively little downside. "The use of AI for this purpose is low-risk, keeps the clinician in the loop, and can be easily implemented."
Why this matters for healthcare professionals
The consensus among these three leaders - who approach the issue from health IT architecture, AI policy, and clinical practice - is that AI will not replace physicians anytime soon. Instead, increasingly capable systems will augment clinicians by reducing administrative burden, applying evidence-based guidance consistently, and helping organizations extend scarce clinical resources. The speed at which that future arrives will depend on whether healthcare can establish the governance, accountability, and trust needed to deploy AI responsibly. For now, the industry's most important challenge is not creating an artificial physician. It is building artificial intelligence that makes human clinicians better.
Your membership also unlocks:
